Thu. 9 May 2024, 8:13am ET
Benzinga
Earnings, Earnings Beats, News
Eledon Pharma (NASDAQ:ELDN) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimate of $(0.39) by 12.82 percent. This is a 54.67 percent increase over losses of $(0.75) per share from the same period last year.